This IQVIA insight brief examines how Southeast Asia and Pakistan are rapidly becoming attractive destinations for global clinical research. The report highlights the region’s large and diverse patient populations, improving healthcare infrastructure, evolving regulatory frameworks, and growing site readiness. Countries such as Indonesia, Malaysia, Singapore, Thailand, Vietnam, the Philippines, and Pakistan offer strong recruitment potential, particularly in oncology, infectious diseases, cardiovascular conditions, and neurology. IQVIA outlines country-specific advantages, regulatory pathways, clinical trial startup timelines, and site network capabilities, demonstrating how sponsors can leverage the region for efficient patient recruitment, cost-effective study execution, and scalable cli

Join for free to read